CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells

Immunology

Volumn 154, Issue 1, 2018, Pages 122-131

  Schiavoni, Ilaria ^a   Scagnolari, Carolina ^b   Horenstein, Alberto L ^c,d   Leone, Pasqualina ^a   Pierangeli, Alessandra ^b   Malavasi, Fabio ^c,d,e   Ausiello, Clara M ^a   Fedele, Giorgio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e Intensive Care and Emergency Città della Salute e della Scienza Hospital   (Italy)

Author keywords

inflammation; interferons; monocyte derived dendritic cells; respiratory syncytial virus

Indexed keywords

ACETYLCYSTEINE; ADENOSINE; ADP RIBOSYL CYCLASE/CYCLIC ADP RIBOSE HYDROLASE 1; CYANIDIN 3 GLUCOSIDE; INTERFERON; INTERLEUKIN 29; ANTIVIRUS AGENT; CD38 PROTEIN, HUMAN; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; ENZYME INHIBITOR; MEMBRANE PROTEIN; REACTIVE OXYGEN METABOLITE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CATALYSIS; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IN VITRO STUDY; INFLAMMATION; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SIGNAL TRANSDUCTION; VIROLOGY;

ADP-RIBOSYL CYCLASE 1; ANTIVIRAL AGENTS; CELLS, CULTURED; CYCLIC ADP-RIBOSE; DENDRITIC CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON TYPE I; MEMBRANE GLYCOPROTEINS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SIGNAL TRANSDUCTION;

EID: 85038120671     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12873     Document Type: Article

References (53)

1. Afonso CL, Amarasinghe GK, Bányai K, Bào Y, Basler CF, Bavari S et al. Taxonomy of the order Mononegavirales: update 2016. Arch Virol 2016; 161:2351–60.
2. Hall CB. The burgeoning burden of respiratory syncytial virus among children. Infect Disord Drug Targets 2012; 12:92–7.
3. Meissner HC. Viral bronchiolitis in children. N Engl J Med 2016; 374:62–72.
4. Koponen P, Helminen M, Paassilta M, Luukkaala T, Korppi M. Preschool asthma after bronchiolitis in infancy. Eur Respir J 2012; 39:76–80.
5. Voraphani N, Stern DA, Wright AL, Guerra S, Morgan WJ, Martinez FD. Risk of current asthma among adult smokers with respiratory syncytial virus illnesses in early life. Am J Respir Crit Care Med 2014; 190:392–8.
6. Jorquera PA, Anderson L, Tripp RA. Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis. Expert Rev Vaccines 2016; 15:173–87.
7. Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM et al. American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014; 134:e1474–502 [Erratum in: Pediatrics 2015; 136:782].
8. González PA, Bueno SM, Carreño LJ, Riedel CA, Kalergis AM. Respiratory syncytial virus infection and immunity. Rev Med Virol 2012; 22:230–44.
9. Farrag MA, Almajhdi FN. Human respiratory syncytial virus: role of innate immunity in clearance and disease progression. Viral Immunol 2016; 29:1–26.
10. Neyt K, Lambrecht BN. The role of lung dendritic cell subsets in immunity to respiratory viruses. Immunol Rev 2013; 255:57–67.
11. Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, Morii E et al. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 2007; 27:240–52.
12. Hillyer P, Mane VP, Chen A, Dos Santos MB, Schramm LM, Shepard RE et al. Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells. Virology 2017; 504:63–72.
13. McNamara PS, Flanagan BF, Hart CA, Smyth RL. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2005; 191:225–32.
14. Mukherjee S, Lukacs NW. Innate immune responses to respiratory syncytial virus infection. Curr Top Microbiol Immunol 2013; 372:139–54.
15. Goritzka M, Durant LR, Pereira C, Salek-Ardakani S, Openshaw PJ, Johansson C. Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J Virol 2014; 88:6128–36.
16. Garofalo RP, Kolli D, Casola A. Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities. Antioxid Redox Signal 2013; 18:186–217.
17. Schiavoni I, Fedele G, Quattrini A, Bianco M, Schnoeller C, Openshaw PJ et al. Live attenuated B. Pertussis BPZE1 rescues the immune functions of respiratory syncytial virus infected human dendritic cells by promoting Th1/Th17 responses. PLOS ONE 2014; 9:e100166.
18. Frasca L, Fedele G, Deaglio S, Capuano C, Palazzo R, Vaisitti T et al. CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 2006; 107:2392–9.
19. Howard M, Grimaldi JC, Bazan JF, Lund FE, Santos-Argumedo L, Parkhouse RM et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 1993; 262:1056–9.
20. Guse AH, da Silva CP, Berg I, Skapenko AL, Weber K, Heyer P et al. Regulation of calcium signaling in T lymphocytes by the second messenger cyclic ADP-ribose. Nature 1999; 398:70–3.
21. Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 2008; 88:841–86.
22. Partida-Sanchez S, Gasser A, Fliegert R, Siebrands CC, Dammermann W, Shi G et al. Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by adp-ribose, the major product generated by the CD38 enzyme reaction. J Immunol 2007; 179:827–39.
23. Lee DC, Harker JA, Tregoning JS, Atabani SF, Johansson C, Schwarze J et al. CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol 2010; 84:8790–8.
24. Selvaggi C, Pierangeli A, Fabiani M, Spano L, Nicolai A, Papoff P et al. Interferon lambda 1–3 expression in infants hospitalized for RSV or HRV associated bronchiolitis. J Infect 2014; 68:467–77.
25. Loebbermann J, Schnoeller C, Thornton H, Thornton H, Durant L, Sweeney NP et al. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLOS ONE 2012; 7:e32371.
26. Bauvois B, Durant L, Laboureau J, Barthélémy E, Rouillard D, Boulla G et al. Upregulation of CD38 gene expression in leukemic B cells by interferon types I and II. J Interferon Cytokine Res 1999; 19:1059–66.
27. Lee S, Paudel O, Jiang Y, Yang XR, Sham JS. CD38 mediates angiotensin II-induced intracellular Ca(2 +) release in rat pulmonary arterial smooth muscle cells. Am J Respir Cell Mol Biol 2015; 52:332–41.
28. Guan XH, Liu XH, Hong X, Zhao N, Xiao YF, Wang LF et al. CD38 deficiency protects the heart from ischemia/reperfusion injury through activating SIRT1/FOXOs-mediated antioxidative stress pathway. Oxid Med Cell Longev 2016; 2016:7410257.
29. Hosakote YM, Liu T, Castro SM, Garofalo RP, Casola A. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol 2009; 41:348–57.
30. Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS Jr, Bakaletz LO et al. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol 2007; 81:9790–800.
31. Saito T, Deskin RW, Casola A, Häeberle H, Olszewska B, Ernst PB et al. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect 1997; 175:497–504.
32. González-Sanz R, Mata M, Bermejo-Martín J, Álvarez A, Cortijo J, Melero JA et al. ISG15 is upregulated in respiratory syncytial virus infection and reduces virus growth through protein ISGylation. J Virol 2016; 90:3428–38.
33. Engelmann I, Dubos F, Lobert PE, Houssin C, Degas V, Sardet A et al. Diagnosis of viral infections using myxovirus resistance protein A (MxA). Pediatrics 2015; 135:e985–93.
34. Walseth TF, Lee HC. Synthesis and characterization of antagonists of cyclic-ADP-ribose-induced Ca2+ release. Biochim Biophys Acta 1993; 1178:235–42.
35. White TA, Kannan MS, Walseth TF. Intracellular calcium signaling through the cADPR pathway is agonist specific in porcine airway smooth muscle. FASEB J 2003; 17:482–4.
36. Kellenberger E, Kuhn I, Schuber F, Muller-Steffner H. Flavonoids as inhibitors of human CD38. Bioorg Med Chem Lett 2011; 21:3939–42.
37. Escande C, Nin V, Price NL, Capellini V, Gomes AP, Barbosa MT et al. Flavonoid apigenin is an inhibitor of the NAD+ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes 2013; 62:1084–93.
38. American Academy of Pediatrics Committee on Infectious Diseases. American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014; 134:415–20.
39. Reid E, Charleston B. Type I and III interferon production in response to RNA viruses. J Interferon Cytokine Res 2014; 34:649–58.
40. Makris S, Pulsen M, Johansson C. Type I Interferons as regulators of lung inflammation. Front Immunol 2017; 8:259.
41. Bacharier LB, Cohen R, Schweiger T, Yin-Declue H, Christie C, Zheng J et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2012; 130:91–100.
42. Wei W, Graeff R, Yue J. Roles and mechanisms of the CD38/cyclic adenosine diphosphate ribose/Ca/2+ signaling pathway. World J Biol Chem 2014; 5:58–67.
43. Choe CU, Lardong K, Gelderblom M, Ludewig P, Leypoldt F, Koch-Nolte F et al. CD38 exacerbates focal cytokine production, postischemic inflammation and brain injury after focal cerebral ischemia. PLOS ONE 2011; 6:e19046.
44. Deaglio S, Robson SC. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol 2011; 61:301–32.
45. Wei W, Lu Y, Hao B, Zhang K, Wang Q, Miller AL et al. CD38 is required for neural differentiation of mouse embryonic stem cells by modulating reactive oxygen species. Stem Cells 2015; 33:2664–73.
46. Partida-Sanchez S, Cockayne DA, Monard S, Jacobson EL, Oppenheimer N, Garvy B et al. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat Med 2001; 7:1209–16.
47. Zhang F, Jin S, Yi F, Xia M, Dewey WL, Li PL. Local production of O2- by NAD(P)H oxidase in the sarcoplasmic reticulum of coronary arterial myocytes: cADPR-mediated Ca2+ regulation. Cell Signal 2008; 20:637–44.
48. Um MY, Ahn J, Ha TY. Hypolipidaemic effects of cyanidin 3-glucoside rich extract from black rice through regulating hepatic lipogenic enzyme activities. J Sci Food Agric 2013; 93:3126–8.
49. Francis FJ. Food colorants: anthocyanins. Crit Rev Food Sci Nutr 1989; 28:273–314.
50. Vaisitti T, Audrito V, Serra S, Buonincontri R, Sociali G, Mannino E et al. The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. Leukemia 2015; 29:356–68.
51. Ciocoiu M, Badescu L, Miron A, Badescu M. The Involvement of a polyphenol-rich extract of black chokeberry in oxidative stress on experimental arterial hypertension. Evid Based Complement Alternat Med 2013; 2013:912769.
52. Ferrari D, Speciale A, Cristani M, Fratantonio D, Molonia MS, Ranaldi G et al. Cyanidin-3-O-glucoside inhibits NF-kB signaling in intestinal epithelial cells exposed to TNF-α and exerts protective effects via Nrf2 pathway activation. Toxicol Lett 2016; 264:51–8.
53. Komaravelli N, Tian B, Ivanciuc T, Mautemps N, Brasier AR, Garofalo RP et al. Respiratory syncytial virus infection down-regulates antioxidant enzyme expression by triggering deacetylation-proteasomal degradation of Nrf2. Free Radic Biol Med 2015; 88:391–403.